Keywords: Russia, Pharma production, RusNano, Domain Associates

Domain partners with RusNano on drug production in Russia

Article | 07 March 2012

Print This

Russian state nanotechnology corporation RusNano and Domain Associates, a US venture fund, are to invest $380 million each in the development ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in